B. Riley Securities Initiates Coverage On Palisade Bio with Buy Rating, Announces Price Target of $7
Benzinga Newsdesk 9 months ago
NewsPrice TargetInitiationAnalyst Ratings
B. Riley Securities analyst William Woods initiates coverage on Palisade Bio (NASDAQ:PALI) with a Buy rating and announces Price Target of $7.
B. Riley Securities analyst William Woods initiates coverage on Palisade Bio (NASDAQ:PALI) with a Buy rating and announces Price Target of $7.